MRVI (STOCKS)
Maravai LifeSciences Holdings, Inc. Class A Common Stock
$4.960000
-0.020000 (-0.40%)
Prev close: $4.980000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Bernd Brust
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,279.33M
- Employees
- 560
- P/E (TTM)
- -6.86
- P/B (TTM)
- 3.47
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $204.73M |
| Benefits Costs and Expenses | $393.54M |
| Cost Of Revenue | $144.76M |
| Costs And Expenses | $267.86M |
| Gross Profit | $59.97M |
| Operating Expenses | $228.23M |
| Selling, General, and Administrative Expenses | $134.65M |
| Research and Development | $16.40M |
| Other Operating Expenses | $77.18M |
| Operating Income/Loss | -$168.26M |
| Income/Loss From Continuing Operations After Tax | -$184.29M |
| Income/Loss From Continuing Operations Before Tax | -$188.81M |
| Income Tax Expense/Benefit | -$4.53M |
| Net Income/Loss | -$184.29M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$79.73M |
| Net Income/Loss Attributable To Parent | -$104.56M |
| Net Income/Loss Available To Common Stockholders, Basic | -$104.56M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.71 |
| Diluted Earnings Per Share | -$0.71 |
| Basic Average Shares | 435,586,000 |
| Diluted Average Shares | 435,586,000 |
| Assets | $713.22M |
| Current Assets | $251.74M |
| Inventory | $40.46M |
| Other Current Assets | $211.27M |
| Noncurrent Assets | $461.48M |
| Intangible Assets | $144.89M |
| Other Non-current Assets | $316.59M |
| Liabilities | $344.13M |
| Current Liabilities | $42.62M |
| Accounts Payable | $8.54M |
| Other Current Liabilities | $34.09M |
| Noncurrent Liabilities | $301.51M |
| Long-term Debt | $241.01M |
| Other Non-current Liabilities | $60.50M |
| Equity | $369.08M |
| Equity Attributable To Noncontrolling Interest | $157.52M |
| Equity Attributable To Parent | $211.56M |
| Liabilities And Equity | $713.22M |
| Net Cash Flow From Operating Activities | -$39.52M |
| Net Cash Flow From Operating Activities, Continuing | -$39.52M |
| Net Cash Flow From Investing Activities | -$12.71M |
| Net Cash Flow From Investing Activities, Continuing | -$12.71M |
| Net Cash Flow From Financing Activities | -$66.83M |
| Net Cash Flow From Financing Activities, Continuing | -$66.83M |
| Exchange Gains/Losses | -$75.00K |
| Net Cash Flow | -$119.13M |
| Net Cash Flow, Continuing | -$119.06M |
| Comprehensive Income/Loss | -$184.04M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | -$79.62M |
| Comprehensive Income/Loss Attributable To Parent | -$104.42M |
| Other Comprehensive Income/Loss | $248.00K |